Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking applications for implementation research to reduce the burden of noncommunicable diseases (NCDs) in low- and middle-income countries (LMICs) and Tribal Nations during critical life stages and key transition periods. The research should focus on the adoption and integration of evidence-based practices, interventions, and policies into routine health care and public health settings to improve impact on population health. The funding opportunity will utilize the R01 (Clinical Trial Optional) and R61/R33 (Clinical Trial Required) activity codes. Some key points to consider: • The research should be conducted in LMICs or Tribal Nations. • The research should focus on NCDs, such as hypertension, lung diseases, diabetes, mental health, cancer, and hypertension/diabetes intervention scale-up. • The research should utilize implementation science methodologies, including partnerships with key stakeholder groups and the development and testing of ways to effectively and efficiently integrate evidence-based practices, interventions, and policies into routine health settings. • The funding opportunity is open to US and LMIC institutions, with eligible LMIC institutions defined by the World Bank. • The application due date is August 10, 2022.